scholarly journals Regulatory mechanism of gastric acid secretion and mucosal integrity. An analysis with various gene deficient mice.

2002 ◽  
Vol 120 (3) ◽  
pp. 159-171 ◽  
Author(s):  
Susumu OKABE ◽  
Kazuharu FURUTANI ◽  
Kazuhiko MAEDA ◽  
Takeshi AIHARA ◽  
Teruaki FUJISHITA ◽  
...  
2000 ◽  
Vol 14 (10) ◽  
pp. 1365-1370 ◽  
Author(s):  
F. Borrelli ◽  
N. J. Welsh ◽  
G. Sigthorsson ◽  
R. Simpson ◽  
A. Palizban ◽  
...  

1990 ◽  
Vol 259 (1) ◽  
pp. G41-G47 ◽  
Author(s):  
D. J. Stechschulte ◽  
D. C. Morris ◽  
R. L. Jilka ◽  
D. J. Stechschulte ◽  
K. N. Dileepan

Gastric acid secretion in normal (+/+) C57B1/6J mice and congeneic, mast cell-deficient (mi/mi) C57B1/6J mice was examined. The mast cell-deficient animals had approximately 50% of the normal quantity of gastric histamine and a blunted basal acid level and secretory response. These observations were noted despite the presence of parietal cells, which were normal in number and morphology. The H2-antagonist ranitidine inhibited basal acid secretion in both groups of animals. Exogenous histamine induced a significant secretory response in normal and mast cell-deficient groups, but only the secretory response in normal animals could be blocked by the H2-antagonist. Treatment of mast cell-deficient animals with histamine for seven consecutive days before stimulation did not restore the histamine response to the normal (+/+) levels. The normal animals demonstrated an acid secretory response to pentagastrin. Mast cell-deficient mice also responded to pentagastrin, but the response was less than that observed in the normal animals, and a significant difference was not evident in all experiments. Furthermore, simultaneous injection of mast cell-deficient animals with histamine and pentagastrin did not restore pentagastrin responsiveness to normal levels, although the histamine concentration used was sufficient to raise acid secretion to basal levels of normal mice. These results support the conclusion that non-mast cell histamine only partially contributes to basal gastric acid secretion and is insufficient to facilitate full parietal cell responsiveness. Furthermore, pentagastrin requires the presence of mast cells to elicit a maximal secretory response but can use non-mast cell histamine to activate the parietal cells for acid secretion.


1998 ◽  
Vol 274 (3) ◽  
pp. G561-G568 ◽  
Author(s):  
Lennart Friis-Hansen ◽  
Frank Sundler ◽  
Ying Li ◽  
Patrick J. Gillespie ◽  
Thomas L. Saunders ◽  
...  

To further understand the role of the peptide hormone gastrin in the development and function of the stomach, we have generated gastrin-deficient mice by gene targeting in embryonic stem cells. Mutant mice were viable and fertile, without obvious visible abnormalities. However, gastric function was severely affected by the loss of gastrin. Basal gastric acid secretion was abolished and could not be induced by histamine, carbachol, or gastrin. Histological analysis revealed alterations in the two cell types primarily involved in acid secretion, parietal and enterochromaffin-like (ECL) cells. Parietal cells were reduced in number with an accumulation of immature cells lacking H+-K+-adenosinetriphosphatase (H+-K+-ATPase). ECL cells were positioned closer to the base of the gastric glands, with markedly lower expression of histidine decarboxylase. Gastrin administration for 6 days reversed the effects of the gastrin deficiency, leading to an increase in the number of mature, H+-K+-ATPase-positive parietal cells and a partial restoration of acid secretion. The results show that gastrin is critically important for the function of the acid secretory system.


2000 ◽  
Vol 278 (1) ◽  
pp. G121-G127 ◽  
Author(s):  
P. Li ◽  
T.-M. Chang ◽  
D. Coy ◽  
W. Y. Chey

Pituitary adenylate cyclase-activating polypeptide (PACAP), existing in two variants, PACAP-27 and PACAP-38, is found in the enteric nervous system and regulates function of the digestive system. However, the regulatory mechanism of PACAP on gastric acid secretion has not been well elucidated. We investigated the inhibitory action of PACAP-27 on acid secretion and its mechanism in isolated vascularly perfused rat stomach. PACAP-27 in four graded doses (5, 10, 20, and 50 μg/h) was vascularly infused to determine its effect on basal and pentagastrin (50 ng/h)-stimulated acid secretion. To study the inhibitory mechanism of PACAP-27 on acid secretion, a rabbit antisecretin serum, antisomatostatin serum, or indomethacin was administered. Concentrations of secretin, somatostatin, PGE2, and histamine in portal venous effluent were measured by RIA. PACAP-27 dose-dependently inhibited both basal and pentagastrin-stimulated acid secretion. PACAP-27 at 10 μg/h significantly increased concentrations of secretin, somatostatin, and PGE2 in basal or pentagastrin-stimulated state. The inhibitory effect of PACAP-27 on pentagastrin-stimulated acid secretion was reversed 33% by an antisecretin serum, 80.0% by an antisomatostatin serum, and 46.1% by indomethacin. The antisecretin serum partially reduced PACAP-27-induced local release of somatostatin and PGE2. PACAP-27 at 10 μg/h elevated histamine level in portal venous effluent, which was further increased by antisomatostatin serum. However, antisomatostatin serum did not significantly increase acid secretion. It is concluded that PACAP-27 inhibits both basal and pentagastrin-stimulated gastric acid secretion. The effect of PACAP-27 is mediated by local release of secretin, somatostatin, and PGE2 in isolated perfused rat stomach. The increase in somatostatin and PGE2 levels in portal venous effluent is, in part, attributable to local action of the endogenous secretin.


1998 ◽  
Vol 114 ◽  
pp. A1135
Author(s):  
D Chen ◽  
T Koh ◽  
C-M Zhao ◽  
R Håkanson ◽  
TC Wang

2015 ◽  
Vol 24 (6) ◽  
pp. 1417-1434 ◽  
Author(s):  
Omar M. E. Abdel-Salam ◽  
Rania Abdallah Ali Salama ◽  
Ezz-Eddin El-Denshary ◽  
Amany Ameen Sleem ◽  
Marawa El-Sayed El-Shamarka ◽  
...  

2000 ◽  
Vol 82 ◽  
pp. 31
Author(s):  
Satoshi Tanaka ◽  
Satoru Takahashi ◽  
Hiroshi Ohtsu ◽  
Takehiko Watanabe ◽  
Susumu Okabe ◽  
...  

1999 ◽  
Vol 277 (1) ◽  
pp. G6-G11 ◽  
Author(s):  
Timothy C. Wang ◽  
Graham J. Dockray

The role of gastrin in the regulation of gastrointestinal growth and acid secretion has been addressed through recent studies involving transgenic and knockout mice. The role of gastrin as a key modulator of parietal cell function and gastric acid secretion has been confirmed through studies in mice deficient in either gastrin or the gastrin/CCK-B receptor. However, although gastrin-deficient mice show no changes in gastric proliferation, they do show reduced colonic proliferation, and rates of colonic proliferation are increased in transgenic mice overexpressing glycine-extended gastrin or progastrin. This themes article highlights recent progress in our understanding of the biology of gastrin through studies in genetically modified mice.


2008 ◽  
Vol 121 (2) ◽  
pp. 88-95 ◽  
Author(s):  
W. Goering ◽  
I.M. Adham ◽  
B. Pasche ◽  
J. Männer ◽  
M. Ochs ◽  
...  

2002 ◽  
Vol 122 (1) ◽  
pp. 145-155 ◽  
Author(s):  
Satoshi Tanaka ◽  
Kiyomi Hamada ◽  
Noboru Yamada ◽  
Yuko Sugita ◽  
Shunsuke Tonai ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document